NCT05981066View on ClinicalTrials.gov

A Clinical Study of mRNA Vaccine (ABOR2014/IPM511) in Patients With Advanced Hepatocellular Carcinoma

NARecruitingINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

July 10, 2023

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2025

Conditions
Advanced Hepatocellular Carcinoma
Interventions
DRUG

Neoantigen vaccine, I.M injection

Patients will receive a fixed applicable dose of ABOR2014(IPM511) administered.

Trial Locations (1)

100730

RECRUITING

Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing

All Listed Sponsors
lead

Peking Union Medical College Hospital

OTHER